Neuroscience, Год журнала: 2025, Номер 577, С. 300 - 314
Опубликована: Май 19, 2025
Язык: Английский
Neuroscience, Год журнала: 2025, Номер 577, С. 300 - 314
Опубликована: Май 19, 2025
Язык: Английский
Neuroscience, Год журнала: 2025, Номер 569, С. 161 - 183
Опубликована: Фев. 7, 2025
Язык: Английский
Процитировано
2European Journal of Pharmacology, Год журнала: 2025, Номер unknown, С. 177509 - 177509
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
1Molecular Psychiatry, Год журнала: 2024, Номер unknown
Опубликована: Дек. 11, 2024
The antidepressant efficacy and safety of seltorexant monotherapy in major depressive disorder (MDD) was investigated a placebo-controlled, placebo lead-in, randomized, double-blind, phase 1b study. Participants were randomized to receive (20 mg or 40 mg) placebo. treatment effect assessed by changes the Hamilton Rating Scale for Depression-17 item (HDRS
Язык: Английский
Процитировано
4Cell Reports, Год журнала: 2025, Номер 44(2), С. 115277 - 115277
Опубликована: Фев. 1, 2025
Highlights•Ox2R is expressed in distinct molecular sub-populations of MCH neurons•Orexin B elicits excitatory and inhibitory responses neurons•Ox2R inactivation neurons impairs REM sleep female mice•Ox2R insulin sensitivity miceSummaryOrexin/hypocretin receptor type 2 (Ox2R), which widely the brain, receives orexin signals modulates metabolism. Ox2R selective agonists are currently under clinical trials for narcolepsy treatment. Here, we focused on expression function melanin-concentrating hormone (MCH) neurons, have opposite roles to metabolism regulation. Ox2R-expressing showed heterogeneity RNA expression, application brain slices induced both neuron populations. reduced transitions from non-rapid eye movement (NREM) impaired with excessive feeding after a fasting period mice. In conclusion, mediates vivo, regulate mice.Graphical abstract
Язык: Английский
Процитировано
0Naunyn-Schmiedeberg s Archives of Pharmacology, Год журнала: 2025, Номер unknown
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0Scientific Reports, Год журнала: 2025, Номер 15(1)
Опубликована: Апрель 8, 2025
Язык: Английский
Процитировано
0Scientific Reports, Год журнала: 2025, Номер 15(1)
Опубликована: Апрель 22, 2025
Язык: Английский
Процитировано
0Experimental Eye Research, Год журнала: 2025, Номер unknown, С. 110395 - 110395
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Scientific Reports, Год журнала: 2025, Номер 15(1)
Опубликована: Апрель 23, 2025
Diabetic Retinopathy (DR) is a leading cause of vision impairment globally, necessitating regular screenings to prevent its progression severe stages. Manual diagnosis labor-intensive and prone inaccuracies, highlighting the need for automated, accurate detection methods. This study proposes novel approach early DR by integrating advanced machine learning techniques. The proposed system employs three-phase methodology: initial image preprocessing, blood vessel segmentation using Hopfield Neural Network (HNN), feature extraction through an Attention Mechanism-based Capsule (AM-CapsuleNet). features are optimized Taylor-based African Vulture Optimization Algorithm (AVOA) classified Bilinear Convolutional (BCAN). To enhance classification accuracy, introduces hybrid Electric Fish Arithmetic (EFAOA), which refines exploration phase, ensuring rapid convergence. model was evaluated on balanced dataset from APTOS 2019 Blindness Detection challenge, demonstrating superior performance in terms accuracy efficiency. offers robust solution DR, potentially improving patient outcomes timely precise diagnosis.
Язык: Английский
Процитировано
0Progress in Neuro-Psychopharmacology and Biological Psychiatry, Год журнала: 2025, Номер 139, С. 111375 - 111375
Опубликована: Апрель 23, 2025
Язык: Английский
Процитировано
0